Based on the findings of the age‐based subgroup analysis, IBD patients aged ≥18 years displayed increased levels of serum hepcidin versus healthy individuals (22.36 ng/mL, 95% CI, 2.12–42.61; p = .030; Table 2). The gene discussed is HAMP; the disease is inflammatory bowel disease.